Terms: = Breast cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
46 results:
1. Obstetrics and Gynecology Care in Latinx Communities.
Hamilton FL; Pleasant V
Obstet Gynecol Clin North Am; 2024 Mar; 51(1):105-124. PubMed ID: 38267122
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and breast cancer Cells.
Devi S; Gründemann C; Huber R; Kowarschik S
Complement Med Res; 2023; 30(5):386-392. PubMed ID: 36927644
[TBL] [Abstract] [Full Text] [Related]
3. Brief Post-Surgical Stress Management Reduces Pro-Inflammatory Cytokines in Overweight and Obese breast cancer Patients Undergoing Primary treatment.
Ream M; Saez-Clarke E; Taub C; Diaz A; Frasca D; Blomberg BB; Antoni MH
Front Biosci (Landmark Ed); 2022 May; 27(5):148. PubMed ID: 35638415
[TBL] [Abstract] [Full Text] [Related]
4. Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on breast cancer Bone Microenvironment.
Iuliani M; Simonetti S; Ribelli G; Napolitano A; Longo UG; Vincenzi B; Orsaria P; Denaro V; Tonini G; Santini D; Francesco P
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269621
[TBL] [Abstract] [Full Text] [Related]
5. Hereditary breast and Ovarian cancer: An Updated Primer for OB/GYNs.
Bellcross CA
Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
[TBL] [Abstract] [Full Text] [Related]
6. Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.
Zuo Q; Chen KL; Arredondo Eve A; Liu YJ; Kim SH; Katzenellenbogen BS; Katzenellenbogen JA; Madak-Erdogan Z
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684335
[TBL] [Abstract] [Full Text] [Related]
7. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy.
Takada K; Kashiwagi S; Asano Y; Goto W; Ishihara S; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2021 Oct; 21(1):1129. PubMed ID: 34670511
[TBL] [Abstract] [Full Text] [Related]
8. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
Mattila PO; Babar ZU; Suleman F
BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
[TBL] [Abstract] [Full Text] [Related]
9. The robustness of VMAT radiotherapy for breast cancer with tissue deformations.
Rossi M; Virén T; Heikkilä J; Seppälä J; Boman E
Med Dosim; 2021 Spring; 46(1):86-93. PubMed ID: 32994095
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.
Schmitz R; Mao R; Moris D; Strickler JH; Blazer DG
Ann Surg Oncol; 2021 Jan; 28(1):114-120. PubMed ID: 32556871
[TBL] [Abstract] [Full Text] [Related]
11. Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.
Sanges F; Floris M; Cossu-Rocca P; Muroni MR; Pira G; Urru SAM; Barrocu R; Gallus S; Bosetti C; D'Incalci M; Manca A; Uras MG; Medda R; Sollai E; Murgia A; Palmas D; Atzori F; Zinellu A; Cambosu F; Moi T; Ghiani M; Marras V; Santona MC; Canu L; Valle E; Sarobba MG; Onnis D; Asunis A; Cossu S; Orrù S; De Miglio MR
BMC Cancer; 2020 Jun; 20(1):491. PubMed ID: 32487046
[TBL] [Abstract] [Full Text] [Related]
12. Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer.
Kirzinger MWB; Vizeacoumar FS; Haave B; Gonzalez-Lopez C; Bonham K; Kusalik A; Vizeacoumar FJ
BMC Med Genomics; 2019 Jul; 12(1):112. PubMed ID: 31351478
[TBL] [Abstract] [Full Text] [Related]
13. The impact of occupation-based problem-solving strategies training in women with breast cancer.
Şahin S; Uyanık M
Health Qual Life Outcomes; 2019 Jun; 17(1):104. PubMed ID: 31208425
[TBL] [Abstract] [Full Text] [Related]
14. WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history.
Kingsberg SA; Larkin L; Krychman M; Parish SJ; Bernick B; Mirkin S
Menopause; 2019 Feb; 26(2):124-131. PubMed ID: 30130293
[TBL] [Abstract] [Full Text] [Related]
15. Ocimum basilicum but not Ocimum gratissimum present cytotoxic effects on human breast cancer cell line MCF-7, inducing apoptosis and triggering mTOR/Akt/p70S6K pathway.
Torres RG; Casanova L; Carvalho J; Marcondes MC; Costa SS; Sola-Penna M; Zancan P
J Bioenerg Biomembr; 2018 Apr; 50(2):93-105. PubMed ID: 29589262
[TBL] [Abstract] [Full Text] [Related]
16. Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
Katsuta E; Yan L; Nagahashi M; Raza A; Sturgill JL; Lyon DE; Rashid OM; Hait NC; Takabe K
J Surg Res; 2017 Nov; 219():202-213. PubMed ID: 29078883
[TBL] [Abstract] [Full Text] [Related]
17. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
[TBL] [Abstract] [Full Text] [Related]
18. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
[TBL] [Abstract] [Full Text] [Related]
19. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract] [Full Text] [Related]
20. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
[TBL] [Abstract] [Full Text] [Related]
[Next]
